Why New Antibiotics Stalled
7:24–7:55 · 31s
Maryn explains the brutal economics of antibiotic R&D: a decade and a billion dollars to market, with resistance ticking from day one.
7:24–7:55 · 31s
Maryn explains the brutal economics of antibiotic R&D: a decade and a billion dollars to market, with resistance ticking from day one.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.